Remarkable progress has been made over the past decade in the molecular imaging of atherosclerotic lesion. The majority of studies have focused on the peptide based probes, which is monovalent and rapidly cleared from systemic circulation, leading to low targeting efficiency and contrast ratio. Thus, more and more efforts are toward using nanoparticle based molecular probe for targeted plaque imaging due to the tunable pharmacokinetics and multivalency. Of various nanoplatforms, core-shell polymeric nanoparticles are of particular interest owing to the flexible design of structures with accurate control of functional groups for multi- applications. Among an array of biomarkers upregulated on atherosclerotic lesion, chemokine receptors are promising targets owing to their critical roles in the initialization and progression of disease. Recently, we have developed chemokine receptors targeted Comb nanoparticles conjugated with novel peptides and labeled with 64Cu for atherosclerosis PET imaging. These targeted nanoagents demonstrated the sensitivity and targeting specificity in experimental mouse ApoE-/- model. In the proposed project, we will optimize the construction of viral macrophage protein-II (vMIP-II) conjugated Comb nanoparticles targeting a group of chemokine receptors and D-ala-peptide T-amide (DAPTA) conjugated Comb nanoparticles specifically targeting CCR5. Our preliminary PET imaging showed specific accumulation of 64Cu-vMIP-Comb and 64Cu-DAPTA-Comb at the aortic arch in ApoE-/- mice. However, the targeting efficiency and target-to-background ratio need further improvement. Thus, we will increase the number of vMIP-II peptide conjugated on each Comb nanoparticle and optimize the pegylation for enhanced targeting efficiency and reduce the blood circulation for minimized non-specific binding. The preferred vMIP-Comb will be used to determine the sensitivity and specificity in early stage of atherosclerosis. For DAPTA-Comb, we will follow the same strategy to optimize the nanostructure for in vitro screening in CCR5+ cell line. The candidate DAPTA-Com will be evaluated in ApoE-/- mice with significant lesion (Specific Aim 1). Then we will use the candidate vMIP-Comb and DAPTA-Comb to determine whether they can detect variation in atherosclerosis burden or progression. We will further analyze the specific cell type associated with radiolabeled nanoparticles in atherosclerotic lesion and correlate the PET signals obtained with the two nanoagents to the pathological examination including plaque area and macrophage area (Specific Aim 2). We anticipate that the targeted nanoparticles will provide sensitive and specific detection of chemokine receptors at plaque and serve as useful tools to detect the burden and progression of atherosclerotic plaque.

Public Health Relevance

Chemokine receptors have been widely studied for their critical roles in the initialization, progression, and clinical events of atherosclerosis. This proposal describes two radiolabeled nanoparticles targeting a group of chemokine receptors and CCR5, respectively. The candidate nanoagents will be used to determine the atherosclerosis burden and progression under various disease conditions and stages. Pathological examination will be performed to study the specific cell type associated with plaque progression.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL125655-02
Application #
8966559
Study Section
Nanotechnology Study Section (NANO)
Program Officer
Danthi, Narasimhan
Project Start
2014-12-01
Project End
2019-11-30
Budget Start
2015-12-01
Budget End
2016-11-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Li, Wenjun; Luehmann, Hannah P; Hsiao, Hsi-Min et al. (2018) Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography-Based Imaging-Brief Report. Arterioscler Thromb Vasc Biol 38:1030-1036
Hsiao, Hsi-Min; Fernandez, Ramiro; Tanaka, Satona et al. (2018) Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1?. J Clin Invest 128:2833-2847
Liu, Yongjian; Woodard, Pamela K (2018) Chemokine receptors: Key for molecular imaging of inflammation in atherosclerosis. J Nucl Cardiol :
Bajpai, Geetika; Schneider, Caralin; Wong, Nicole et al. (2018) The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med 24:1234-1245
Williams, Jesse W; Elvington, Andrew; Ivanov, Stoyan et al. (2017) Thermoneutrality but Not UCP1 Deficiency Suppresses Monocyte Mobilization Into Blood. Circ Res 121:662-676
Liu, Yongjian; Gunsten, Sean P; Sultan, Deborah H et al. (2017) PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation. Radiology 283:758-768
Luehmann, Hannah P; Detering, Lisa; Fors, Brett P et al. (2016) PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles. J Nucl Med 57:1124-9
Baba, Osamu; Liu, Yongjian; Randolph, Gwendalyn J (2016) Defensin-chemokine heteromeric complexes derived from heterocellular activation-a possible target to inhibit CCL5 in cardiovascular settings. Ann Transl Med 4:497
Liu, Y; Li, W; Luehmann, H P et al. (2016) Noninvasive Imaging of CCR2+ Cells in Ischemia-Reperfusion Injury After Lung Transplantation. Am J Transplant 16:3016-3023
Kazuma, Soraya M; Sultan, Deborah; Zhao, Yongfeng et al. (2015) Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis. Curr Pharm Des 21:5267-76